Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Evaluation of the Everolimus Eluting Bioresorbable Vascular Scaffold System (BVS) for the Treatment of Subjects With Critical Limb Ischemia (CLI) From Occlusive Vascular Disease of the Tibial Arteries

NCT01341340 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.

NCT NCT01341340
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01341340 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Evaluation of the Everolimus Eluting Bioresorbable Vascular Scaffold System (BVS) for the Treatment of Subjects With Critical Limb Ischemia (CLI) From Occlusive Vascular Disease of the Tibial Arteries
Lead sponsor
Abbott Medical Devices
Phase
Not applicable
Overall status
Terminated
Start date
November 30, 2011
Completion date
November 30, 2012
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerosis, claudication, critical limb ischemia, lower limb disease, pad, paod, peripheral arterial occlusive disease, peripheral artery disease, peripheral vascular disease, pvd